Lupin Limited has recently announced the launch of Lupin Diagnostics in India. Lupin Diagnostics, a wholly-owned subsidiary of Lupin, has formally begun operations in India as part of the company’s objective to deliver comprehensive healthcare.
The company has established a state-of-the-art National Reference Laboratory in Navi Mumbai. Lupin Diagnostics will offer a wide variety of diagnostic tests including molecular diagnostics, flow cytometry, cytogenetics, serology, microbiology, histology and cytology, haematology, and immunology.
“The health and well-being of our customers is our top priority at Lupin. Combining decades of experience and knowledge in the field of therapeutics, we aim to provide our doctors, patients, and consumers with the same experience offering quality diagnostic services that are built on trust. I am delighted to announce the launch of Lupin Diagnostics enabling customers across India to obtain more accurate results with personalized insights, built on a backbone of quality standards and controls that are unrivalled. Our experienced team of Pathologists, Microbiologists, and Geneticists, along with a trained technical support team will ensure that each customer receives high-quality diagnostic care.”Mr. Nilesh Gupta, Managing Director, Lupin
“The pandemic has elevated healthcare to the top of the global agenda. The role of diagnostics is crucial to improving the health and well-being of society,” said Rajeev Sibal, President, India Region Formulations, Lupin. “We are pleased to announce the launch of Lupin Diagnostics, which will provide consumers with the best-in-class diagnostics services with the highest quality standards in the industry. With a world-class infrastructure and equipment, seasoned doctors, supported by well-qualified technologists, we will provide a comprehensive array of diagnostic tests.”
“Doctors increasingly rely on high-quality diagnostic tests to formulate a treatment and disease management plan that is evidence-based. Diagnostics results are an important part of this decision-making while managing the journey of a patient,” said Ravindra Kumar, Vice President & Head, Lupin Diagnostics. “By building on Lupin’s market leadership position, we are well-positioned to lead and shape Lupin’s diagnostics business in India.”
The official report states, ‘The core facilities of the laboratory include all major diagnostics services, preventive health checkups, and a comprehensive range of tests. All the processing will be operated by Lupin Healthcare as a hub and will be connected to a nationwide network of regional, satellite, and collection centers. In addition, Lupin is identifying franchisee partners who are willing to serve the needs of patients with a singular motto of ‘Quality & Care’.’
Healthcare plays an important role and after the Covid wave, diagnostic labs are dealing with the increased workload. We hope that the entry of Lupin in diagnostic services will play a key role in making the diaspora of this service better.